News
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
By Stephanie Brown HealthDay ReporterWEDNESDAY, July 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...
But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results